A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin resistance in overweight individuals, mediated by gut permeability and inflammation. Effects were linked to BMI but not observed in non-overweight participants during short-term exposure.
Sanofi licenses fourth NK cell engager from Innate Pharma – Pharmaceutical Technology
Share this article Sanofi has already licensed four programmes from Innate Pharma – with two of those in Phase II clinical trials. Image credit: Shutterstock/JHVEPhoto.
December 19, 2023